DR3:TL1A Inhibitor Screening Assay Kit
The DR3:TL1A Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of the interaction between DR3 (Death Receptor 3) and TL1A (TNF-like ligand 1A) . This kit comes in a convenient 96-well or 384-well format, with biotin-labeled TL1A (amino acids 72-end), purified DR3 (amino acids 25-199), streptavidin-labeled HRP, and assay buffer for 100 or 400 binding reactions.Figure 1:DR3:TL1A Inhibitor Screening Assay Kit workflow diagram.First, DR3 is coated on a 96-well or 384-well plate. Next, biotinylated TL1A is incubated with DR3. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence. The chemiluminescence signal is proportional to the binding of DR3:TL1ANeed us to run inhibitor screens or profile your compounds against DR3:TL1A? Check out ourImmunotherapy Biochemical Screening Services.
Product Specifications
Background
UniProt
O95150
Applications
Format
Storage Conditions
This assay kit will perform optimally for up to 6 months from date of receipt when the materials are stored as directed
Notes
Contraindications
The final concentration of DMSO in the assay should not exceed 1%.
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog